Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MFAT vs Corticosteroid for Shoulder Osteoarthritis
NCT04929951Phase 1Recruiting
- Sponsor
- Stanford University
- Start
- Jul 2022
- Primary completion
- Dec 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of microfragmented adipose tissue in shoulder osteoarthritis (2 arms), sponsored by Stanford University. Primary endpoint: American Shoulder and Elbow Surgeons Score at 24 months. Started Jul 2022; status: recruiting.
02
Drugs
microfragmented adipose tissue
03
Conditions
shoulder osteoarthritis
Beyond the preview
Go deeper on NCT04929951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04929951.